EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Immunomodulation of salivary gland function due to cancer therapy

Ana C Costa-da-Silva, Carlos U Villapudua, Matthew P Hoffman, Marit H Aure iD

Oral Diseases · 2025-09 · 31 (9) · 2680-2694

DOI: 10.1111/odi.14972 ↗

At a glance

Übersichtsarbeit in Oral Diseases, published online on 2024-05-02. Written by Ana C Costa-da-Silva and 3 co-authors. Institution: Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA. Major MEDLINE topics: Salivary Glands, Immunomodulation, Neoplasms, Salivary Gland Diseases. Cited 4 times so far (Crossref); 100 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Intramural NIH HHS, NIH HHS, National Institutes of Health.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Functional salivary glands (SG) are essential for maintaining oral health, and salivary dysfunction is a persistent major clinical challenge. Several cancer therapies also have off‐target effects leading to SG dysfunction. Recent advances highlight the role of SG immune populations in homeostasis, dysfunction and gland regeneration. Here, we review what is known about SG immune populations during development and postnatal homeostasis. We summarize recent findings of immune cell involvement in SG dysfunction following cancer treatments such as irradiation (IR) for head and neck cancers, immune transplant leading to graft‐versus‐host‐disease (GVHD) and immune checkpoint inhibitor (ICI) treatment. The role of immune cells in SG in both homeostasis and disease, is an emerging field of research that may provide important clues to organ dysfunction and lead to novel therapeutic targets.

Subjects

MeSH terms (MEDLINE)

Salivary GlandsImmunomodulationNeoplasmsSalivary Gland DiseasesHumansImmune Checkpoint InhibitorsGraft vs Host DiseaseHead and Neck Neoplasms

Author keywords

GVHDcheckpoint inhibitor therapyirradiationregenerationsalivary glandsalivary hypofunctiontissue resident immune cells

Substances

Immune Checkpoint Inhibitors

Authors and institutions

  • Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
  • Matrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.

ORCID profiles: Marit H Aure

Funding

  • Intramural NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Costa-da-Silva, A. C., Villapudua, C. U., Hoffman, M. P., & Aure, M. H. (2025). Immunomodulation of salivary gland function due to cancer therapy. Oral Diseases, 31(9), 2680-2694. https://doi.org/10.1111/odi.14972

Vancouver

Costa-da-Silva AC, Villapudua CU, Hoffman MP, Aure MH. Immunomodulation of salivary gland function due to cancer therapy. Oral Diseases. 2025;31(9):2680-2694. doi:10.1111/odi.14972

BibTeX
@article{CostadaSilva2025,
  author = {Costa-da-Silva, Ana C and Villapudua, Carlos U and Hoffman, Matthew P and Aure, Marit H},
  title = {Immunomodulation of salivary gland function due to cancer therapy},
  journal = {Oral Diseases},
  year = {2025},
  volume = {31},
  number = {9},
  pages = {2680--2694},
  doi = {10.1111/odi.14972}
}
Start for free →